Litcius/Paper detail

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study

Maximilian Stahl, Rory M. Shallis, Wei Wei, Pau Montesinos, Étienne Lengliné, Judith Neukirchen, Vijaya Raj Bhatt, Mikkael A. Sekeres, Amir T. Fathi, Heiko Konig, Selina M. Luger, Irum Khan, Gail J. Roboz, Thomas Cluzeau, David Martínez‐Cuadrón, Emmanuel Raffoux, Ulrich Germing, Jayadev Manikkam Umakanthan, Sudipto Mukherjee, Andrew M. Brunner, Adam R. Miller, Christine M. McMahon, Ellen K. Ritchie, Rebeca Rodríguez‐Veiga, Raphaël Itzykson, Blanca Boluda, Florence Rabian, Mar Tormo, Evelyn Acuña‐Cruz, Emma Rabinovich, Brendan Yoo, Isabel Cano, Nikolai A. Podoltsev, Jan Philipp Bewersdorf, Steven D. Gore, Amer M. Zeidan

2020Leukemia97 citationsDOIOpen Access PDF

Topics & Concepts

LeukapheresisMedicineLeukostasisHazard ratioProportional hazards modelInternal medicineMyeloid leukemiaSurgeryLeukemiaConfidence intervalStem cellBiologyGeneticsCD34Acute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationRetinoids in leukemia and cellular processes
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study | Litcius